# Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment

> **NCT07550634** · PHASE1 · NOT_YET_RECRUITING · sponsor: **MindRank AI Ltd** · enrollment: 32 (estimated)

## Conditions studied

- Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B)
- Hepatic Insufficiency (MeSH ID: D048550)

## Interventions

- **DRUG:** MDR-001

## Key facts

- **NCT ID:** NCT07550634
- **Lead sponsor:** MindRank AI Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2026-07-08
- **Final completion:** 2026-10-30
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07550634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07550634, "Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07550634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*